IL-37通过TGF-β/Smad3通路抑制炎症反应来缓解败血症引起的肺损伤

Yufang Guo1,2, Feifei Deng1, Yali Jiang1,3

  • 1Department of Critical Care Medicine, The Friendship Hospital of Ili Kazakh Autonomous Prefecture, Yili, Xinjiang, P.R. China.

PubMed
概括

干白素37 (IL-37) 减少炎症和肺损伤在败血症患者和动物模型. 这种细胞因子通过降低细胞亡和炎症通路的调节来缓解败血症引起的肺损伤.